Accordingly, we believe that PINK1 is a highly potential target for the treatment of bone metabolism‐related diseases such as osteoporosis and bone defect, and deserves further efforts to explore its application value in clinical treatment. The gene discussed is PINK1; the disease is osteoporosis.